Keywords: clinical, trials, round-up, coulter, pharmaceutical, reported, follow-up
Clinical trials round-up
Article | 10 June 1999
- Coulter Pharmaceutical has reported follow-up data from 432 heavilypretreated non-Hodgkin's lymphoma patients who received therapy with the company's antibody drug Bexxar ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
